3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Postoperative Cognitive Complications
1
Neoplasms
1
Malnutrition
1
Liver Diseases
1
Gastrointestinal Neoplasms
1
Frailty
1
Emergence Delirium
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Fluorouracil
13
pembrolizumab
12
Paclitaxel
12
Oxaliplatin
12
Leucovorin
9
Carboplatin
9
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Cisplatin
7
Radiotherapy
6
Radiation
6
Taxes
5
Esophagectomy
5
Drug Therapy
5
Surgical Procedures, Operative
4
Specimen Handling
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Control Groups
×
90 days
×
Clear all
No trials found.